Streetbeat News

Corporate Responsibility

IKNA

Ikena Oncology shares are trading higher after the company announced it will discontinue development of IK-930 and evaluate strategic options for both the Company and its development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:17 pm

NBIX

Neurocrine Biosciences announced that CEO Kevin Gorman will retire on October 11, 2024, and will be succeeded by Kyle Gano, Ph.D., the current Chief Business Development and Strategy Officer. Gano will also join the Board of Directors, while Gorman will continue to serve on the Board.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:16 pm

FPI

Farmland Partners has appointed Susan Landi as the new Chief Financial Officer (CFO).

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:14 pm

CMPX

Compass Therapeutics has appointed Thomas Schuetz as President and CEO, effective May 28, 2024. Vered Bisker-Leib has stepped down but will remain as a Senior Consultant for the next 15 months.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:13 pm

ANIK

Anika Therapeutics has entered into a cooperation agreement with Caligan Partners and appointed Joseph Capper and William Jellison to its Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:09 pm

FTHM

Fathom Holdings has appointed Jon Gwin as its new Chief Operating Officer (COO).

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:08 pm

EIS

SPY

John Kirby, NSC Coordinator for Strategic Communications, stated that the U.S. condemns the loss of innocent life in Rafah. This statement may have implications for defense and geopolitical sectors.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:50 pm

MSFT

OpenAI, backed by Microsoft, has formed a new board committee to evaluate the safety and security of its AI models. This move follows the resignation of key executives and the disbanding of an internal team. The committee will assess safeguards over 90 days and share updates publicly.

Portfolio Pulse from Shivani Kumaresan

May 28, 2024 | 6:27 pm

DD

RSPM

TINT

BofA Securities analyst Steve Byrne raised the price target for DuPont de Nemours, Inc. (NYSE:DD) from $74 to $80 while maintaining an Underperform rating. The analyst believes DuPont's strategic split into three companies could unlock value, particularly in the Water and Electronics businesses, but PFAS liabilities remain a significant risk. Investors can gain exposure to DuPont through ProShares Smart Materials ETF (NYSE:TINT) and Invesco S&P 500 Equal Weight Materials ETF (NYSE:RSPM).

Portfolio Pulse from Lekha Gupta

May 28, 2024 | 6:14 pm

BZFD

BuzzFeed Inc (NASDAQ:BZFD) shares are trading higher after Vivek Ramaswamy, a former 2024 presidential candidate, wrote a letter to BuzzFeed’s board and revealed an increased stake in the company. Ramaswamy now holds an 8.37% stake and is advocating for significant strategic changes to improve the company's performance.

Portfolio Pulse from Adam Eckert

May 28, 2024 | 6:02 pm